Rifaximin Placebo

DRUG3 trials

Sponsors

Tampa General Hospital, Assistance Publique - Hôpitaux de Paris, Fayoum University Hospital

Conditions

Adherent-invasive E. ColiCrohn DiseaseHepatic EncephalopathyLiver CirrhosisPortal HypertensionThrombocytopenia Related to Chronic Liver Disease

Phase 2

Evaluation of Adherent Invasive E. Coli Eradication in Adult Crohn Disease

TerminatedNCT02620007

Assistance Publique - Hôpitaux de ParisCrohn Disease, Adherent-invasive E. Coli

Start: 2015-12-31End: 2022-06-30Updated: 2023-08-23

Phase 4

Quality of Life and Nutritional Improvements in Cirrhotic Patients

TerminatedNCT01842113

Tampa General HospitalLiver Cirrhosis, Hepatic Encephalopathy, Portal Hypertension

Start: 2013-04-30Updated: 2013-09-23

Effect of Rifaximin on Thrombocytopenia in Patients With HCV-Related Liver Cirrhosis

CompletedNCT07791940

Fayoum University HospitalThrombocytopenia Related to Chronic Liver Disease

Start: 2015-10-19End: 2016-12-30Updated: 2026-08-28